Ocugen (OCGN) Net Income towards Common Stockholders (QoQ) (2014 - 2025)
Ocugen (OCGN) Net Income towards Common Stockholders (QoQ) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -138.29% |
| Dec 31, 2023 | -438.35% |
| Sep 30, 2023 | 49.20% |
| Jun 30, 2023 | -0.93% |
| Mar 31, 2023 | -4.16% |
| Dec 31, 2022 | -0.08% |
| Sep 30, 2022 | 19.26% |
| Jun 30, 2022 | 18.95% |
| Mar 31, 2022 | -129.74% |
| Dec 31, 2021 | -35.57% |
| Sep 30, 2021 | 58.56% |
| Jun 30, 2021 | 54.19% |
| Mar 31, 2021 | -1,394.85% |
| Dec 31, 2020 | 63.82% |
| Sep 30, 2020 | 35.19% |
| Jun 30, 2020 | -305.36% |
| Mar 31, 2020 | -132.20% |
| Dec 31, 2019 | 154.37% |
| Sep 30, 2019 | -543.53% |
| Jun 30, 2019 | 62.33% |